MedTrace Logo

Efficacy of Buffered Lidocaine in Patients With Facial Swelling

NCT01981772 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2020-10-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the clinical efficacy of a buffered 4% lidocaine solution for incision and drainage. Ninety patients will be examined clinically to determine a diagnosis of cellulitis or fluctuance. The diagnosis will be confirmed by incision and drainage. Patients will receive either 3.6 ml 4% lidocaine with 1:100,000 epinephrine or 3.6 ml 4% lidocaine with 1:100,000 epinephrine buffered with 8.4% sodium bicarbonate. Patients will rate pain prior to and throughout the procedure.

Conditions

  • Orofacial Swelling

Interventions

DRUG

4% lidocaine with 1:100,000 epinephrine

see arm/group description

DRUG

4% buffered lidocaine with 1:100,000 epinephrine

see arm/group description

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Melissa Drum, DDS, MS · The Ohio State University College of Dentistry

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01981772 on ClinicalTrials.gov